Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The approval was supported by data from the Phase III ADRIATIC study, which according to an April 2024 readout hit its primary efficacy endpoints of overall survival and progression-free survival (PFS)
They were primarily introduced to treat type 2 diabetes, and in recent years their use for weight management has soared particularly in the US, where data suggests around 12% of adults have taken them for this purpose
Together, they may produce an additive tachycardic effectelevated resting heart rateand sustained blood pressure elevation that increases strain on the heart over time
Eat First: Never drink on an empty stomach
Tirzepatide use was associated with a significant reduction in AMI (RRR: 42%, HR: 0.59
Zepbound (tirzepatide) , works by stimulating both GLP-1 and GIP receptors to enhance metabolic regulation
